Zarontin Gets High Marks for Kids' Epilepsy
Study Shows the Anticonvulsant Drug Works Best for Absence Epilepsy
March 4, 2010 -- One of the oldest drugs used to treat the most common form of pediatric epilepsy is also the most effective, a study shows.
As many as 17% of children with epilepsy have absence seizures, also known as petit mal seizures, which involve brief but frequent staring spells that can occur dozens or even hundreds of times a day.
These children do not have the convulsions typically associated with epilepsy, but they are at high risk for developing them later in life.
During the 10- to 15-second seizure episodes, people with absence epilepsy become unresponsive and may stop walking or talking in mid-sentence. Children with these seizures often perform poorly in school.
The anticonvulsant drugs ethosuximide (Zarontin), valproic acid (Depakote, Depakene), and lamotrigine (Lamictal) are all used to treat the disorder, but there is no consensus on which drug is best for the initial treatment of children experiencing absence seizures.
"One reason we started this study was that we saw regional differences in how absence epilepsy was being treated," study researcher Tracy A. Glauser, MD, of Cincinnati Children's Hospital, tells WebMD. "These medications have different side effect profiles, and it wasn't at all clear which one was the best drug to start with."
Zarontin the 'Clear Winner'
Glauser and colleagues conducted a trial to compare the effectiveness and side effects of the three drugs in children with absence epilepsy who had received no prior treatment.
Their findings appear in the March 4 issue of the New England Journal of Medicine.
The trial was conducted at 32 sites across the U.S.; it included 156 children initially treated with Zarontin, 149 treated with Lamictal, and 148 treated with Depakote.
Zarontin, used since the late 1950s, is the oldest and cheapest of the three drugs, and the only one used exclusively for the treatment of absence epilepsy.
Depakote was introduced several years later and is also used to treat other seizure disorders, bipolar disorder, and migraines.
Approved for the treatment of seizures in 1994, Lamictal is the newest of the drugs. It is also used to treat bipolar disorder and is being studied for the treatment of migraines.